Dostarlimab (Anti-PDCD1 / PD-1 / CD279)
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1 programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61581R-BF488-TR 20 µL
PHD2 Recombinant Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details